Glen Harbor Capital Management LLC lowered its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 42.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,256 shares of the company’s stock after selling 27,104 shares during the period. Glen Harbor Capital Management LLC owned approximately 0.07% of Nu Skin Enterprises worth $2,672,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wolverine Asset Management LLC increased its holdings in shares of Nu Skin Enterprises by 106.9% during the 4th quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock worth $103,000 after buying an additional 23,378 shares during the last quarter. Cerebellum GP LLC acquired a new stake in shares of Nu Skin Enterprises during the 4th quarter worth approximately $124,000. Centaurus Financial Inc. acquired a new stake in shares of Nu Skin Enterprises during the 1st quarter worth approximately $136,000. Amundi Pioneer Asset Management Inc. acquired a new stake in shares of Nu Skin Enterprises during the 4th quarter worth approximately $192,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Nu Skin Enterprises by 38.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after buying an additional 858 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.
Nu Skin Enterprises opened at $80.95 on Friday, MarketBeat Ratings reports. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.14 and a quick ratio of 0.75. The company has a market cap of $4.54 billion, a P/E ratio of 25.06, a P/E/G ratio of 2.74 and a beta of 1.34. Nu Skin Enterprises, Inc. has a fifty-two week low of $53.50 and a fifty-two week high of $81.82.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Thursday, April 26th. The company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.09. The firm had revenue of $616.00 million during the quarter, compared to analysts’ expectations of $564.46 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.36%. The firm’s quarterly revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the company posted $0.51 EPS. equities analysts forecast that Nu Skin Enterprises, Inc. will post 3.56 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 13th. Shareholders of record on Friday, May 25th will be given a $0.365 dividend. The ex-dividend date is Thursday, May 24th. This represents a $1.46 annualized dividend and a yield of 1.80%. Nu Skin Enterprises’s dividend payout ratio is presently 45.20%.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $72.69, for a total value of $218,070.00. Following the completion of the transaction, the general counsel now owns 44,399 shares of the company’s stock, valued at approximately $3,227,363.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Pisano R. Thomas sold 15,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 7th. The shares were sold at an average price of $72.00, for a total transaction of $1,080,000.00. Following the completion of the transaction, the director now directly owns 47,437 shares of the company’s stock, valued at approximately $3,415,464. The disclosure for this sale can be found here. Insiders sold a total of 121,474 shares of company stock valued at $9,039,111 in the last three months. 5.20% of the stock is currently owned by corporate insiders.
A number of analysts have recently issued reports on the stock. Citigroup raised their price target on shares of Nu Skin Enterprises from $81.00 to $82.00 and gave the stock a “buy” rating in a report on Monday, April 30th. Pivotal Research restated a “buy” rating and set a $90.00 price target on shares of Nu Skin Enterprises in a report on Friday, February 16th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Zacks Investment Research cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. Finally, Stifel Nicolaus increased their price objective on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the stock a “sell” rating in a research report on Friday, February 16th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Nu Skin Enterprises currently has an average rating of “Hold” and a consensus price target of $73.50.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.